PAHO Recommendation regarding the use of Ivermectin as a treatment for COVID-19

24 June 2020

A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications on observational clinical studies reported the apparent utility of ivermectin to treat patients with COVID-19 needing mechanical ventilation; neither of these studies were peer-reviewed nor formally published and one of them was later retracted. Please see the attached document for more information.

PAHO Recommendation Regarding the Use of Ivermectin as a Treatment for COVID-19 (381.44 KB)